Eyecheck Announces FDA IND Clearance of STRI Formula, the First-Ever Food-Based, Combination Product in the STRI Phase 2 Clinical Trial for COVID-19 Symptoms
Eyecheck intends to initiate the Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial to evaluate STRI Formula in non-hospitalized adults with COVID-19. This trial is expected to begin in November 2021. - November 04, 2021
Eyecheck Launches PRISTENE™ for Dry Eye Syndrome
Eyecheck, LLC announced today the formal launch of PRISTENE™, their second in a family of eye health supplements. “It is gratifying that our company has made such great progress in 2017 and we are so pleased to now offer PRISTENE™ to our clinicians and their patients to assist in... - November 06, 2017
Press Releases 1 - 2 of 2